Prevent predominance of cholinergic system with.....
An anticholinergic drug to negate cholinergic predominance.
- Crosses the blood-brain barrier and blocks muscarinic receptors.
Helps balancing side effects of antidopaminergic drugs.
Indicated In :
Parkinsons disease :
idiopathic (paralysis agitans), postencephalitic and arteriosclerotic
Antipsychotic induced dysphoria & akathisia
As adjunct with levodopa therapy
Dosage and administration :
Parkinsons disease :
Starting dose : 2.5 mg. t.i.d.
Maintenance dose : 15 to 30 mg. per day.